C83.76
Burkitt lymphoma, intrapelvic lymph nodes
Clinical Classification Guidelines
Medical Intelligence & Overview
Burkitt lymphoma is an aggressive form of non-Hodgkin lymphoma that typically affects lymph nodes and other parts of the body. When it involves intrapelvic lymph nodes, it specifically affects the lymphatic structures within the pelvic region. This type of lymphoma may present with rapid growth and require prompt medical attention. Despite its aggressive nature, early diagnosis and treatment can significantly improve outcomes.
Causes & Symptoms
Clinical Causes: Genetic mutations, particularly involving the MYC gene Infections such as the Epstein-Barr virus (EBV) Immune system deficiencies or suppression Environmental factors, though specific causes are not well-established Age-related susceptibility, more common in children and young adults
Key Symptoms: Swelling or a noticeable lump in the pelvic area Pain or discomfort in the pelvis or abdomen Unexplained weight loss Persistent fever or night sweats Fatigue and weakness Digestive disturbances like nausea or bowel changes Potential blood in stool or other unusual bleeding
Diagnostic & Treatment
Diagnosis Path: Diagnosis of intrapelvic Burkitt lymphoma involves multiple steps, including medical history review and physical examination. Confirmatory tests include:
Treatment Protocols: Management of Burkitt lymphoma typically requires intensive therapy. Treatment strategies include:
Clinical Advice & FAQs
Billing Guidance
Is C83.76 a billable ICD-10 code?
Yes, C83.76 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.76?
Clinical documentation must specify the nature of Burkitt lymphoma, intrapelvic lymph nodes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference